| Indumathi Baskar, MD | |
|
1241 W Stadium Blvd, Jefferson City, MO 65109-6023 | |
| (573) 635-5264 | |
| (573) 761-4351 |
| Full Name | Indumathi Baskar |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 1241 W Stadium Blvd, Jefferson City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083634331 | NPI | - | NPPES |
| 770152 | Other | MO | HEALTHLINK |
| P00384937 | Other | MO | MEDICARE RAILROAD |
| 215614 | Other | MO | BCBS |
| 295310 | Other | MO | GHP |
| CC7852 | Other | MO | RAILROAD GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2006016360 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Missouri Home Health | Jefferson city, MO | Home health agency |
| Capital Region Home Health | Jefferson city, MO | Home health agency |
| Elara Caring | Jefferson city, MO | Home health agency |
| Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
| Capital Region Medical Center | Jefferson city, MO | Hospital |
| Bothwell Regional Health Center | Sedalia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson City Medical Group Pc | 1850371089 | 97 |
News Archive
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Foundation Medicine Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute have come up with the results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.
Following a rule expanding coverage of weight-loss surgery under Medicare, bariatric procedures in the Medicare population were centralized to a smaller number of certified centers, were more likely to be minimally invasive and were associated with improved outcomes, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
| Entity Name | Jefferson City Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336189398 PECOS PAC ID: 1850371089 Enrollment ID: O20040908000924 |
News Archive
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Foundation Medicine Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute have come up with the results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.
Following a rule expanding coverage of weight-loss surgery under Medicare, bariatric procedures in the Medicare population were centralized to a smaller number of certified centers, were more likely to be minimally invasive and were associated with improved outcomes, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Indumathi Baskar, MD Po Box 104240, Jefferson City, MO 65110-4240 Ph: (573) 635-5264 | Indumathi Baskar, MD 1241 W Stadium Blvd, Jefferson City, MO 65109-6023 Ph: (573) 635-5264 |
News Archive
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the U.S. Food and Drug Administration has granted multiple Orphan Drug Designations for the Company's lead drug candidate, aldoxorubicin, in three indications: glioblastoma multiforme (GBM), small cell lung cancer and ovarian cancer.
Foundation Medicine Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute have come up with the results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.
Following a rule expanding coverage of weight-loss surgery under Medicare, bariatric procedures in the Medicare population were centralized to a smaller number of certified centers, were more likely to be minimally invasive and were associated with improved outcomes, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals.
› Verified 3 days ago
Vineela Kasireddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1432 Southwest Blvd, Jefferson City, MO 65109 Phone: 573-632-4800 | |
Mr. Ghulam Ghous, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5000 Fax: 573-634-2033 | |
Dr. Thomas W. Schneider, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-761-4351 | |
Dr. Conrad S. Balcer, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-761-4611 | |
Rolando Daniel Breier, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-893-6404 Fax: 573-893-6505 | |
Chad Zeglis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2505 Mission Dr, Jefferson City, MO 65109 Phone: 573-681-3396 Fax: 573-681-3617 | |
Dr. Rodd L Hillard, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2707 W Edgewood Dr, Jefferson City, MO 65109 Phone: 573-635-0233 Fax: 573-635-7436 |